These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32730756)

  • 1. Outcomes of donor-derived superinfection screening in HIV-positive to HIV-positive kidney and liver transplantation: a multicentre, prospective, observational study.
    Bonny TS; Kirby C; Martens C; Rose R; Desai N; Seisa M; Petropoulos C; Florman S; Friedman-Moraco RJ; Turgeon NA; Brown D; Segev DL; Durand CM; Tobian AAR; Redd AD
    Lancet HIV; 2020 Sep; 7(9):e611-e619. PubMed ID: 32730756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal analysis of viral dynamics in HIV+-to-HIV+ HOPE Act kidney-transplant recipients.
    Travieso T; Stadtler H; Alavian N; Gao F; Klotman M; Wolfe CR; Blasi M
    J Clin Invest; 2024 Sep; 134(20):. PubMed ID: 39255037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial.
    Kunisaki KM; Niewoehner DE; Collins G; Aagaard B; Atako NB; Bakowska E; Clarke A; Corbelli GM; Ekong E; Emery S; Finley EB; Florence E; Infante RM; Kityo CM; Madero JS; Nixon DE; Tedaldi E; Vestbo J; Wood R; Connett JE;
    Lancet Respir Med; 2016 Dec; 4(12):980-989. PubMed ID: 27773665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Landscape of Human Immunodeficiency Virus-Positive Deceased Organ Donors in the United States.
    Werbel WA; Brown DM; Kusemiju OT; Doby BL; Seaman SM; Redd AD; Eby Y; Fernandez RE; Desai NM; Miller J; Bismut GA; Kirby CS; Schmidt HA; Clarke WA; Seisa M; Petropoulos CJ; Quinn TC; Florman SS; Huprikar S; Rana MM; Friedman-Moraco RJ; Mehta AK; Stock PG; Price JC; Stosor V; Mehta SG; Gilbert AJ; Elias N; Morris MI; Mehta SA; Small CB; Haidar G; Malinis M; Husson JS; Pereira MR; Gupta G; Hand J; Kirchner VA; Agarwal A; Aslam S; Blumberg EA; Wolfe CR; Myer K; Wood RP; Neidlinger N; Strell S; Shuck M; Wilkins H; Wadsworth M; Motter JD; Odim J; Segev DL; Durand CM; Tobian AAR;
    Clin Infect Dis; 2022 Jun; 74(11):2010-2019. PubMed ID: 34453519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-Positive Kidney Donor Selection for HIV-Positive Transplant Recipients.
    Muller E; Barday Z
    J Am Soc Nephrol; 2018 Apr; 29(4):1090-1095. PubMed ID: 29330339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial.
    Cypel M; Feld JJ; Galasso M; Pinto Ribeiro RV; Marks N; Kuczynski M; Kumar D; Bahinskaya I; Bagnato VS; Kurachi C; Slutsky AS; Yeung JC; Donahoe L; de Perrot M; Yasufuku K; Pierre A; Binnie M; Chaparro C; Martinu T; Chen M; Tikkanen J; Chow CW; Sidhu A; Waddell TK; Keshavjee S; Singer LG; Humar A
    Lancet Respir Med; 2020 Feb; 8(2):192-201. PubMed ID: 31606437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study.
    Stock PG; Roland ME; Carlson L; Freise CE; Roberts JP; Hirose R; Terrault NA; Frassetto LA; Palefsky JM; Tomlanovich SJ; Ascher NL
    Transplantation; 2003 Jul; 76(2):370-5. PubMed ID: 12883195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of HIV quasispecies and virological outcome of an HIV D+/R+ kidney-liver transplantation.
    Rozera G; Visco-Comandini U; Giombini E; Santini F; Forbici F; Berno G; Gruber C; De Paolis P; Colonnelli R; D'Offizi G; Ettorre GM; Grossi P; Capobianchi MR; Ippolito G; Abbate I
    Virol J; 2022 Jan; 19(1):4. PubMed ID: 34991646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study.
    Lodi S; Phillips A; Logan R; Olson A; Costagliola D; Abgrall S; van Sighem A; Reiss P; Miró JM; Ferrer E; Justice A; Gandhi N; Bucher HC; Furrer H; Moreno S; Monge S; Touloumi G; Pantazis N; Sterne J; Young JG; Meyer L; Seng R; Dabis F; Vandehende MA; Pérez-Hoyos S; Jarrín I; Jose S; Sabin C; Hernán MA;
    Lancet HIV; 2015 Aug; 2(8):e335-43. PubMed ID: 26423376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In sickness and in health: Living HIV positive kidney donation from a wife to her husband, with 7 years' post-transplant follow-up.
    Grupper A; Goykhman Y; Baruch R; Turner D; Elbirt D; Okrent Smolar L; Katz P; Nachmany I; Lubezky N; Katchman E
    Transpl Infect Dis; 2019 Dec; 21(6):e13171. PubMed ID: 31518477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of Kidney Transplantation from Donors with HIV.
    Durand CM; Massie A; Florman S; Liang T; Rana MM; Friedman-Moraco R; Gilbert A; Stock P; Mehta SA; Mehta S; Stosor V; Pereira MR; Morris MI; Hand J; Aslam S; Malinis M; Haidar G; Small CB; Santos CAQ; Schaenman J; Baddley J; Wojciechowski D; Blumberg EA; Ranganna K; Adebiyi O; Elias N; Castillo-Lugo JA; Giorgakis E; Apewokin S; Brown D; Ostrander D; Eby Y; Desai N; Naqvi F; Bagnasco S; Watson N; Brittain E; Odim J; Redd AD; Tobian AAR; Segev DL;
    N Engl J Med; 2024 Oct; 391(15):1390-1401. PubMed ID: 39413376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
    Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E;
    Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of archived drug resistance mutations in HIV-1 DNA among vertically infected adolescents under antiretroviral treatment in Cameroon: Findings during the COVID-19 pandemic.
    Ka'e AC; Fokam J; Togna Pabo WLR; Nanfack A; Ngoufack Jagni Semengue E; Bouba Y; Nka AD; Tetang S; Beloumou G; Takou D; Chenwi C; Tommo Tchouaket MC; Abba A; Djupsa S; Sosso SM; Pamen NB; Otshudiema JO; Boum Y; Colizzi V; Ndjolo A; Perno CF; Ceccherini-Silberstein F; Santoro MM
    HIV Med; 2023 Jun; 24(6):691-702. PubMed ID: 36717222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes.
    Roland ME; Barin B; Carlson L; Frassetto LA; Terrault NA; Hirose R; Freise CE; Benet LZ; Ascher NL; Roberts JP; Murphy B; Keller MJ; Olthoff KM; Blumberg EA; Brayman KL; Bartlett ST; Davis CE; McCune JM; Bredt BM; Stablein DM; Stock PG
    Am J Transplant; 2008 Feb; 8(2):355-65. PubMed ID: 18093266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver transplantation with hepatitis C virus-infected graft: interaction between donor and recipient viral strains.
    Fan X; Lang DM; Xu Y; Lyra AC; Yusim K; Everhart JE; Korber BT; Perelson AS; Di Bisceglie AM
    Hepatology; 2003 Jul; 38(1):25-33. PubMed ID: 12829983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney and liver organ transplantation in persons with human immunodeficiency virus: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(4):1-56. PubMed ID: 23074407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of donor-derived hepatitis C viral infection in three transplant recipients from a donor at increased risk for bloodborne pathogens.
    Shah AP; Cameron A; Singh P; Frank AM; Fenkel JM
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28060446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HOPE springs eternal: lack of HIV superinfection in HIV Organ Policy Equity Act kidney transplants.
    Durand CM; Redd AD
    J Clin Invest; 2024 Oct; 134(20):. PubMed ID: 39403922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial.
    O'Connor J; Vjecha MJ; Phillips AN; Angus B; Cooper D; Grinsztejn B; Lopardo G; Das S; Wood R; Wilkin A; Klinker H; Kantipong P; Klingman KL; Jilich D; Herieka E; Denning E; Abubakar I; Gordin F; Lundgren JD;
    Lancet HIV; 2017 Mar; 4(3):e105-e112. PubMed ID: 28063815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial.
    Molina JM; Grund B; Gordin F; Williams I; Schechter M; Losso M; Law M; Ekong E; Mwelase N; Skoutelis A; Wiselka MJ; Vandekerckhove L; Benfield T; Munroe D; Lundgren JD; Neaton JD;
    Lancet HIV; 2018 Apr; 5(4):e172-e180. PubMed ID: 29352723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.